DK2024493T3 - Fremgangsmåder til udvælgelse af stamceller og anvendelse heraf - Google Patents

Fremgangsmåder til udvælgelse af stamceller og anvendelse heraf

Info

Publication number
DK2024493T3
DK2024493T3 DK07736403.2T DK07736403T DK2024493T3 DK 2024493 T3 DK2024493 T3 DK 2024493T3 DK 07736403 T DK07736403 T DK 07736403T DK 2024493 T3 DK2024493 T3 DK 2024493T3
Authority
DK
Denmark
Prior art keywords
procedures
selection
stem cells
stem
cells
Prior art date
Application number
DK07736403.2T
Other languages
English (en)
Inventor
Nadir Askenasy
Original Assignee
Cellect Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellect Biotechnology Ltd filed Critical Cellect Biotechnology Ltd
Application granted granted Critical
Publication of DK2024493T3 publication Critical patent/DK2024493T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK07736403.2T 2006-05-31 2007-05-31 Fremgangsmåder til udvælgelse af stamceller og anvendelse heraf DK2024493T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80939006P 2006-05-31 2006-05-31
US84001306P 2006-08-25 2006-08-25
PCT/IL2007/000663 WO2007138597A2 (en) 2006-05-31 2007-05-31 Methods of selecting stem cells and uses thereof

Publications (1)

Publication Number Publication Date
DK2024493T3 true DK2024493T3 (da) 2014-10-06

Family

ID=38779094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07736403.2T DK2024493T3 (da) 2006-05-31 2007-05-31 Fremgangsmåder til udvælgelse af stamceller og anvendelse heraf

Country Status (7)

Country Link
US (1) US8435786B2 (da)
EP (1) EP2024493B1 (da)
JP (1) JP2009538615A (da)
AU (1) AU2007266565A1 (da)
CA (1) CA2653881C (da)
DK (1) DK2024493T3 (da)
WO (1) WO2007138597A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
KR101912982B1 (ko) * 2012-03-06 2018-10-29 셀렉트 바이오테라퓨틱스 리미티드 세포자멸사-신호전달 내성 세포를 선택하기 위한 디바이스 및 방법, 그리고 그의 용도
AU2014333391B2 (en) 2013-10-09 2020-02-06 Cellect Biotherapeutics Ltd. Activation of hematopoietic progenitors by pretransplant exposure to death ligands
CN108138142A (zh) * 2015-09-24 2018-06-08 塞莱克特生物疗法有限公司 繁殖用在移植中的间质干细胞（msc）的方法
FR3114492A1 (fr) 2020-09-28 2022-04-01 Poietis Procede de fabrication d’une valve biologique par bio-impression
US20240285692A1 (en) * 2021-06-07 2024-08-29 Cocytus Ltd. Use of death ligands on hematopoietic stem and progenitor cells and mesenchymal stromal cells for cancer therapy

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5654186A (en) * 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
GB9308271D0 (en) * 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5489304A (en) * 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5716616A (en) * 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
CA2230852A1 (en) * 1995-08-30 1997-03-06 The Regents Of The University Of California Therapy for cellular accumulation in chronic inflammatory diseases
JP4162849B2 (ja) * 1997-09-17 2008-10-08 持田製薬株式会社 新規Ｆａｓリガンド誘導体
AU767241B2 (en) * 1998-09-14 2003-11-06 Qiang Xu Immunosuppressive agents
US6184035B1 (en) * 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
RU2249039C2 (ru) * 1999-02-04 2005-03-27 Текнион Рисерч Энд Дивелопмент Фаундейшн Лтд. Способ размножения/поддержания недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты), способ приготовления кондиционированной среды стромальных клеток, способ трансплантации недифференцированных гемопоэтических стволовых клеток или клеток-предшественников (варианты)
US7927602B2 (en) * 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
US20060018885A1 (en) * 2000-11-14 2006-01-26 Ildstad Suzanne T Methods for increasing HSC graft efficiency
JP4330995B2 (ja) * 2001-11-15 2009-09-16 チルドレンズ メディカル センター コーポレーション 絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法
US20040131599A1 (en) * 2002-03-13 2004-07-08 Civin Curt I Fas ligand expressing hematopoietic cells for transplantation
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
WO2004003142A2 (en) * 2002-06-28 2004-01-08 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
WO2004046312A2 (en) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
US20090298045A1 (en) 2004-05-06 2009-12-03 Tel Hashomer-Medical Research, Infrastructure And Services Ltd. Method For Selectively Expanding, Selecting And Enriching Stem/Progenitor Cell Populations
JP2007536936A (ja) * 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
CN101227857B (zh) 2005-06-29 2011-10-19 电脑医师有限公司 具有导电桥的传感器组件

Also Published As

Publication number Publication date
AU2007266565A1 (en) 2007-12-06
CA2653881A1 (en) 2007-12-06
US20100040582A1 (en) 2010-02-18
CA2653881C (en) 2016-08-23
WO2007138597A3 (en) 2008-04-10
EP2024493B1 (en) 2014-07-02
WO2007138597A2 (en) 2007-12-06
EP2024493A2 (en) 2009-02-18
JP2009538615A (ja) 2009-11-12
US8435786B2 (en) 2013-05-07

Similar Documents

Publication Publication Date Title
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2032598T3 (da) Axmi-031, axmi-039, axmi-040 og axmi-049, en familie af deltaendotoksingener og fremgangsmåder til deres anvendelse
DK2001611T3 (da) Fremgangsmåde og sammensætning til oprensning af jord
DK2048941T3 (da) Fremgangsmåde til opdræt af rovmider
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK2414507T3 (da) Mutanter af aktiveringsinduceret cytidin-deaminase (aid) og til anvendelsesfremgangsmåder
DK2084444T4 (da) Testning og udluftning af rør-annulus
DK2297312T3 (da) Alpha-amylasevarianter af Bacillus subtilis og fremgangsmåder til anvendelse heraf
DK2356213T3 (da) Stamcelleaggregatsuspensionssammensætninger og fremgangsmåder til differentiering deraf
DK3081215T3 (da) Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin
DK3133169T3 (da) Fremgangsmåder til selektion og amplificering af polynukleotider
DK2371958T3 (da) HIDTIL UKENDTE siRNA OG FREMGANGSMÅDER TIL ANVENDELSE DERAF
DK3428148T3 (da) Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf
DK2099447T3 (da) Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK2152748T3 (da) Anti-Notch1-NRR-antistoffer og fremgangsmåder til anvendelse deraf
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2217577T3 (da) Hidtil ukendte forbindelser og præparater og fremgangsmåder til anvendelse deraf
DK2494039T3 (da) Fremgangsmåder til reprogrammering af celler og anvendelser deraf
DK3078743T3 (da) Antidoter til faktor xa-inhibitorer og fremgangsmåder til anvendelse af disse
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK1981403T3 (da) Fremgangsmåde og indretning til registrering af kropsbevægelser
DK3092901T3 (da) Quinolonanaloger og fremgangsmåder relateret dertil
DK2229360T3 (da) Indolinonderivater og fremgangsmåde til deres fremstilling
DK2440253T3 (da) Alkylphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
DK2099796T3 (da) Aza-indolyl-forbindelser og fremgangsmåder for anvendelse